Jochen Raimann

A new study in #Med examined the relationship between #UniversalHealthCoverage (UHC) and cancer mortality rates. The findings suggest that higher levels of UHC are associated with decreased mortality rates for various cancers, highlighting the importance of improving access to targeted and effective cancer care in achieving UHC and reducing cancer-related deaths. https://lnkd.in/ejqXTsFS #HealthEquity #GlobalHealth #PublicHealth

12

“We’ve #lost the #contrast between #light and #dark, and we are #confusing our #physiology on a regular basis,” said John Hanifin, PhD, associate #director of Thomas Jefferson University’s Light Research Program. Our own #galaxy is #invisible to nearly 80% of #people in North America. In 1994, an earthquake-triggered #blackout in Los Angeles led to calls to the Griffith Observatory from people wondering about that hazy blob of light in the #night #sky. It was the Milky Way. Glaring #headlights, #illuminated buildings, blazing #billboards, and #streetlights fill our #urban #skies with a #glow that even #affects #rural #residents. Inside, since the invention of the light #bulb, we’ve kept our #homes bright at night. Now, we’ve also added #blue light-emitting #devices — #smartphones, #television screens, #tablets — which have been linked to #sleep #problems. For one 2024 #study, researchers used #satellite data to #measure light #pollution at #residential #addresses of over 13,000 people. They found that those who lived in #places with the brightest skies at night had a 31% #higher risk of high blood pressure. Another study out of Hong Kong showed a 29% higher risk of #death from #coronary #heart #disease. And yet another found a 17% higher risk of #cerebrovascular disease, such as #strokes or #brain #aneurysms. Of course, urban areas also have #air pollution, noise, and a #lack of #greenery. So, for some studies, #scientists #controlled for these #factors, and the #correlation remained strong (although air pollution with fine #particulate #matter appeared to be worse for heart health than outdoor light). Research has revealed that light at night (#indoors or #out) disrupts #circadian #clocks, increases #inflammation, affects #cell division, and #suppresses #melatonin, the “hormone of darkness.” “Darkness is very important,” Hanifin said. When he and his colleagues #decades ago started studying the effects of light on human #physiology, “people thought we were borderline crazy,” he said. The #hormone #melatonin, produced when it’s #dark by the #pineal gland in the #brain, is a key player in this modern struggle. Melatonin helps you sleep, synchronizes the body’s circadian rhythms, protects #neurons from #damage, #regulates the #immunesystem, and fights inflammation. But even a sliver of light at night can #suppress its #secretion. Less than 30 lux of light, about the level of a #pedestrian street at night, can slash melatonin by half. Researchers #concede that #satellite data might be too #coarse to #estimate how much light people are actually #exposed to while they sleep. Plus, many of us are staring at #bright #screens. “But the studies keep coming,” Nelson said, suggesting that outdoor light pollution does have an #impact. https://lnkd.in/gu8DRdWm

3

Framingham Heart Study: 60 Years of Insights! Discover the Framingham Heart Study's six-decade journey, revealing key insights into cardiovascular health. Learn about major findings, risk factors, and prevention strategies that have shaped modern cardiology. #FraminghamHeartStudy #CardiovascularHealth #MedicalResearch #cardio #cardiology

5

Feeling overwhelmed by all of the new generative AI options available? 🚀 Breaking Ground in Healthcare AI: Mass General Brigham Launches Initiative to Evaluate AI Solutions. With FDA-approved AI tools flooding healthcare, Mass General Brigham is taking a collaborative approach to evaluate these new tools. They've just launched the Healthcare AI Challenge - bringing together leading institutions like Emory Healthcare, University of Washington, and the American College of Radiology to evaluate AI solutions from Microsoft, Google, and OpenAI in real clinical settings. What makes this meaningful? • First-of-its-kind interactive virtual testing environment • Starting with radiology, expanding to pathology and genomics • Public sharing of clinician feedback and insights • Real-world validation at the point of care Since 75% of leading healthcare companies explore generative AI (Deloitte), this collaborative approach to testing and validation is timely. This is a good step towards setting practical standards for safe, effective AI implementation in healthcare. #HealthcareInnovation #AI #DigitalHealth #Radiology #FutureOfHealthcare

5

Toward a Biomedical Research Enterprise That Better Serves the United States "The decline of the U.S. biomedical research enterprise would have grave implications not only for scientific progress but also for the national health, economy, and overall prosperity." "we can easily imagine a future in which the United States no longer leads the pack in biomedical innovations and medical breakthroughs" "we need a strategic vision and oversight body, as well as enhanced coordination at the national level" "because of silos and lack of coordination, redundant investigations occur in parallel, and important research questions are left unexplored" "we need a workforce that is adequately compensated and able to focus on the issues that matter most" "It is essential to act now, and act with purpose, to strengthen and reinvigorate the U.S. biomedical research enterprise." National Academy of Medicine The National Institutes of Health National Cancer Institute (NCI) AACI (Association of American Cancer Institutes) The Warren Alpert Medical School of Brown University The New England Journal of Medicine American Association for Cancer Research American Society of Clinical Oncology (ASCO) The Cancer Letter https://lnkd.in/emMBWHHB

12

1 Comment

We're thrilled to share how Dr. Bellamy Brook, a family medicine doctor, has transformed his practice with ScribeRYTE AI. For Dr. Brook, accurate patient records have always been a top priority. Take a moment to read his valuable feedback below: "As a practitioner dedicated to the well-being of my patients, I have always prioritized maintaining meticulous records of our conversations and treatments. With ScribeEMR's ScribeRYTE AI documentation solution, I have found a reliable partner in this endeavor." - Bellamy Brook, D.O., P.C. (Family Medicine). Dr. Brook appreciates how ScribeEMR's AI-powered solution captures every minute detail of patient interactions, creating efficient and accurate documentation, seamlessly integrated with their EMR. Impact? - This has enhanced productivity, reduced costs, and allowed more focus on patient care instead of paperwork. We are grateful for Dr. Brook's feedback, and are committed to supporting healthcare professionals with our innovative technologies. Interested in learning how ScribeRyte AI can benefit your practice? Get in touch today! https://lnkd.in/dK-y2SeH #CustomerTestimonial #HealthcareInnovation #ScribeRyteAI #ScribeEMR #MedicalDocumentation #AIMedicalScribing #PhysicianBurnout #EHRIntegration #HealthTech #AIinHealthcare #DigitalHealth #CustomerExperience

38

1 Comment

Nina Bickell, MD, MPH, discusses her study on leveraging automated technology to enhance the identification, classification, and matching of patients to clinical trials. This innovative approach aims to overcome the limitations of resource-intensive technologies like Natural Language Processing, broadening access to diverse groups and streamlining the recruitment process. "Our research demonstrates the potential of automated systems to significantly improve the efficiency and inclusivity of clinical trial recruitment, ensuring that more patients, especially from diverse backgrounds, can benefit from cutting-edge cancer treatments." — Nina Bickell, MD, MPH #CancerResearch #ClinicalTrials #HealthcareInnovation #DiversityInResearch #MedicalTechnology #Oncology #PatientCare https://lnkd.in/ekRK6r_T

2

🎙️Check out our latest #sarcomatalk on #liposarcoma with Dr. Vinayak Venkataraman MD! OncoDaily #sarcoma #oncology #sarcomaresearch

24

Is the increased cardiovascular risk in #SouthAsians genetically driven? My patients and family tell me so. DNA is not destiny. I agree, however, that there are genetic pathways implicated in baseline cardiovascular risk factors such as diabetes and lipid abnormalities, for example. Great to collaborate with the team at OurHealth (Pradeep Natarajan and Romit Bhattacharya, MD, FACC) to prepare this nice review of genomic studies, pharmacogenetics, and integration of genetic information as it pertains to #SouthAsians into polygenic risk scores to improve cardiovascular risk prediction led by Johns Hopkins Medicine Osler Residency star, Abhi Gami. Ciccarone Center for the Prevention of Heart Disease Anandita Agarwala Kulkarni MD, FACC Payal Kohli, MD, FACC Ankur Kalra Ami Bhatt, MD Martha Gulati Roger Blumenthal Natasha Chida Garima Sharma MD, FACC, FAHA

59

8 Comments

Leveraging Large Language Models to Enhance Infectious Disease Modeling for Public Health Preparedness #PublicHealth #InfectiousDiseases #Epidemiology #MachineLearning #PandemicPreparedness #DataScience #HealthTech Link: https://lnkd.in/eSxeBUa8

1

Congratulations to Dr. Evanthia Roussos Torres, co-leader of the Tumor Immunology and Microenvironment Program, who received fund from the NCI to lead a complementary, multi-disciplinary research team to address interdisciplinary research questions at the nexus of cancer health disparities and cancer immunology with the goal to improve the intractable challenge of high mortality in minority populations with breast cancer by engaging this unique community of patients, their treating physicians, and researchers. Dr. Roussos Torres and her team will investigate differences in the suppressive immune cell composition of breast tumors from Hispanic/Latino patients compared to non-Hispanic White patients. The integration of these research foci will change how we study and identify novel diagnostics and therapeutics for patients with breast cancer. Funding like this will facilitate collaboration between fields that have not traditionally worked hand in hand and provides an exciting platform for novel discovery.

60

6 Comments

"Digital Health Technology Use Across Socioeconomic Groups Before and During the COVID-19 Pandemic." The shift toward #digitalhealth technology in the health ecosystem has seen significant growth in recent years. The #COVID19 pandemic accelerated this transition, emphasizing the importance of digital tools in health delivery and individuals' access to care.. Yet, this digital transformation poses the challenge of creating a potential "digital divide." Varied socioeconomic groups, older individuals, those not tech-savvy, and the economically disadvantaged will likely face barriers to accessing and utilizing digital health technologies effectively. Addressing disparities is crucial to ensuring equitable access to health for all. By understanding and mitigating the factors contributing to the digital divide, we can work toward an inclusive and accessible health system for everyone. This is an important paper that appears in JMIR Publications. #DigitalHealth #HealthTech #COVID19 #HealthDisparities https://lnkd.in/gykzryrs

15

It's an honor to be selected as one of the top 100,000 scientists by c-score (with and without self-citations) or a percentile rank of 2% or above in the sub-field. This is based on the August 1, 2024 snapshot from Scopus, updated to end of citation year 2023. https://lnkd.in/dhn9U3c4

36

13 Comments

Last week’s bipartisan action by 15 senators in support of Medicare beneficiary access to Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) scans could have a potentially positive impact for accessibility of therapies for neurodegenerative disease, including Alzheimer’s. These technologies are critical for precision diagnosis, preventing patients who don’t qualify based on biology from being exposed to treatment unnecessarily, and ensuring patients who do qualify have access to treatment. This is a very encouraging development an estimated 6.9 million Americans 65+ were living with Alzheimer's in 2024, which is about 1 in 9 in that age group, according to Alzheimer's Association®. https://lnkd.in/e3tQb6es

27

2 Comments

Excited to share insights from a recent randomized clinical trial exploring integrating large language models (LLMs) into physician diagnostic reasoning. The study assessed the impact of #LLMs on diagnostic performance compared to conventional resources. Key takeaway: While access to LLMs did not significantly enhance clinical reasoning compared to traditional tools, the #LLM alone outperformed both physician groups in diagnostic accuracy (Goh et al., 2024). These findings highlight the potential of #AI to complement clinical decision-making and the importance of investing in technology and workforce development for meaningful collaboration between healthcare providers and AI. This research was even highlighted by Gina Kolata in The New York Times on Sunday, reflecting the growing public interest in AI's transformative role in #healthcare. https://lnkd.in/dzcWeTsr I hope you find it interesting 🤓 Reference: Goh, E., Gallo, R., Hom, J., Strong, E., Weng, Y., Kerman, H., Cool, J. A., Kanjee, Z., Parsons, A. S., Ahuja, N., Horvitz, E., Yang, D., Milstein, A., Olson, A. P. J., Rodman, A., & Chen, J. H. (2024). Large language model influence on diagnostic reasoning: A randomized clinical trial. JAMA Network Open, 7(10), e2440969. https://lnkd.in/dnmX8cAK

5